의약품 안전성 평가 시장 보고서(2026년)

Pharmaceutical safety assessment involves the systematic evaluation of drugs and pharmaceutical products to confirm their safety and reduce potential risks to patients. It includes the analysis of preclinical and clinical data, monitoring of adverse effects, and adherence to regulatory standards. This process supports informed decision-making regarding the approval, labeling, and safe use of medications.

The main types in the pharmaceutical safety assessment market include in-vitro safety assessment, in-vivo safety assessment, and computational safety assessment. In-vitro safety assessment involves evaluating the safety and toxicity of drugs, chemicals, or other substances through controlled laboratory tests conducted outside a living organism. The different types of drugs comprise biological drugs and chemical drugs. It covers multiple stages, such as preclinical, clinical (phase I, II, III), and post-market surveillance (phase IV). Major end users consist of pharmaceutical companies, biotechnology firms, medical device manufacturers, academic and research institutions, and contract research organizations (CROs).

Tariffs are influencing the pharmaceutical safety assessment market by increasing costs of imported laboratory instruments, analytical software platforms, high-throughput screening systems, and specialized testing equipment used across in-vitro, in-vivo, and computational assessments. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to dependence on imported analytical technologies, while Asia-Pacific faces cost pressure on outsourced safety testing services. These tariffs are increasing operational costs and extending assessment timelines. However, they are also encouraging domestic development of safety assessment tools, regional CRO expansion, and increased adoption of software-based and in-silico safety solutions.

The pharmaceutical safety assessment market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical safety assessment market statistics, including pharmaceutical safety assessment industry global market size, regional shares, competitors with a pharmaceutical safety assessment market share, detailed pharmaceutical safety assessment market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical safety assessment industry. This pharmaceutical safety assessment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical safety assessment market size has grown strongly in recent years. It will grow from $11.32 billion in 2025 to $12.24 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to expansion of pharmaceutical R&D pipelines, increasing regulatory scrutiny on drug safety, growth in preclinical and clinical testing volumes, wider adoption of in-vitro safety assessment methods, rising use of CRO-led safety studies.

The pharmaceutical safety assessment market size is expected to see strong growth in the next few years. It will grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing reliance on computational safety assessment, expansion of personalized medicine development, rising demand for faster regulatory approvals, growing integration of ai in drug safety workflows, increased post-market surveillance requirements. Major trends in the forecast period include increasing use of ai-based toxicity prediction tools, rising adoption of in-silico safety assessment models, growing integration of real-time pharmacovigilance systems, expansion of automated preclinical testing platforms, enhanced focus on regulatory-compliant safety analytics.

The expansion of clinical trials is anticipated to drive the growth of the pharmaceutical safety assessment market in the coming years. Clinical trials are research studies conducted in humans to assess the safety, efficacy, and potential side effects of new medical treatments, drugs, or interventions. The number of clinical trials is increasing due to the rising demand for novel and effective therapies, as researchers and healthcare providers strive to develop treatments that can better prevent, manage, or cure diseases. Clinical trials contribute to pharmaceutical safety assessment by systematically examining a drug's impact on humans through carefully controlled studies, monitoring for adverse effects, determining safe dosage ranges, and providing critical data that regulatory authorities use to ensure medications are both safe and effective for public use. For example, as of September 26, 2025, the National Library of Medicine (NLM), a US-based biomedical library, reported that a total of 554,798 studies were registered on ClinicalTrials.gov. Thus, the growth of clinical trials is supporting the expansion of the pharmaceutical safety assessment market.

Major companies in the pharmaceutical safety assessment market are concentrating on developing AI-powered decision support tools to improve the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool is a software system that employs artificial intelligence to analyze data and provide insights that facilitate faster and more precise decision-making. For example, in April 2024, Charles River Laboratories, a US-based life sciences company, in collaboration with Deciphex, an Ireland-based company specializing in AI-driven quality assurance, launched the Patholytix Foresight platform, an AI-powered decision support tool aimed at transforming toxicologic pathology in pharmaceutical safety assessment. The platform utilizes artificial intelligence to rapidly analyze complex preclinical pathology data, assisting in the earlier identification of potential safety risks and minimizing subjectivity in results. It provides distinctive features such as an AI algorithm for detecting tissue abnormalities, a cloud-based system for global collaboration, and a scalable design that reduces slide review time while enhancing data accuracy and consistency.

In January 2025, Groupe ProductLife S.A.S., a France-based life sciences services company, acquired Stragen Services SAS for an undisclosed amount. Through this acquisition, ProductLife Group intends to strengthen its pharmacovigilance and clinical safety capabilities, broaden its presence in the European market, and offer more comprehensive regulatory and safety support to pharmaceutical and biotech clients. Stragen Services SAS is a France-based company that focuses on pharmaceutical safety assessment, also known as pharmacovigilance.

Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.

North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical safety assessment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical safety assessment market includes revenues earned by entities by providing services such as post-marketing surveillance, safety pharmacology, regulatory consulting and compliance, bioanalytics and biomarker services, and in silico and computational toxicology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Safety Assessment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical safety assessment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical safety assessment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical safety assessment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: In-Vitro Safety Assessment; In-Vivo Safety Assessment; Computational Safety Assessment
• 2) By Drug Type: Biological Drugs; Chemical Drugs
• 3) By Phase: Preclinical; Clinical (Phase I, II, III); Post-Market Surveillance (Phase IV)
• 4) By End User: Pharmaceutical Companies; Biotechnology Companies; Medical Device Companies; Academic And Research Institutions; Contract Research Organizations (CROs)
• Subsegments:
• 1) By In-Vitro Safety Assessment: Cell-Based Assays; Organotypic Models; Tissue Culture Models; High-Throughput Screening
• 2) By In-Vivo Safety Assessment: Rodent Studies; Non-Rodent Studies; Toxicokinetic Studies; Carcinogenicity Studies
• 3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling; Physiologically Based Pharmacokinetic (PBPK) Modeling; Toxicity Prediction Software; In Silico Simulation Studies
• Companies Mentioned: IQVIA Holding Inc.; LabCorp (formerly Covance); Thermo Fisher Scientific (PPD); Charles River Laboratories; ICON plc; Parexel International Corp.; Syneos Health; Eurofins Scientific SE; Wuxi Biologics Inc.; SGS SA; Medpace Holdings Inc.; Fujifilm Wako (Fujifilm Corp.); Pharmaron Beijing Co. Ltd.; Inotiv (incl. Envigo); Evotec (Cyprotex); Intertek Group; Altasciences Inc.; Aragen Life Sciences Ltd.; CTI Clinical Trial and Consulting Inc.; ChemDiv Inc.; Frontage Laboratories; Medicilon Inc.; Biotoxtech Co. Ltd.; BioIVT; Accelera Srl.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Safety Assessment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Pharmaceutical Safety Assessment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Safety Assessment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Pharmaceutical Safety Assessment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Biotechnology, Genomics & Precision Medicine
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Use Of Ai-Based Toxicity Prediction Tools
  • 4.2.2 Rising Adoption Of In-Silico Safety Assessment Models
  • 4.2.3 Growing Integration Of Real-Time Pharmacovigilance Systems
  • 4.2.4 Expansion Of Automated Preclinical Testing Platforms
  • 4.2.5 Enhanced Focus On Regulatory-Compliant Safety Analytics

5. Pharmaceutical Safety Assessment Market Analysis Of End Use Industries

• 5.1 Pharmaceutical Companies
• 5.2 Biotechnology Companies
• 5.3 Medical Device Companies
• 5.4 Academic And Research Institutions
• 5.5 Contract Research Organizations (Cros)

6. Pharmaceutical Safety Assessment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Safety Assessment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Pharmaceutical Safety Assessment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Pharmaceutical Safety Assessment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Pharmaceutical Safety Assessment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Pharmaceutical Safety Assessment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Safety Assessment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Safety Assessment Market Segmentation

• 9.1. Global Pharmaceutical Safety Assessment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment
• 9.2. Global Pharmaceutical Safety Assessment Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biological Drugs, Chemical Drugs
• 9.3. Global Pharmaceutical Safety Assessment Market, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)
• 9.4. Global Pharmaceutical Safety Assessment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)
• 9.5. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vitro Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening
• 9.6. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of In-Vivo Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies
• 9.7. Global Pharmaceutical Safety Assessment Market, Sub-Segmentation Of Computational Safety Assessment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies

10. Pharmaceutical Safety Assessment Market Regional And Country Analysis

• 10.1. Global Pharmaceutical Safety Assessment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Pharmaceutical Safety Assessment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Safety Assessment Market

• 11.1. Asia-Pacific Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Safety Assessment Market

• 12.1. China Pharmaceutical Safety Assessment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Safety Assessment Market

• 13.1. India Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Safety Assessment Market

• 14.1. Japan Pharmaceutical Safety Assessment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Safety Assessment Market

• 15.1. Australia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Safety Assessment Market

• 16.1. Indonesia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Safety Assessment Market

• 17.1. South Korea Pharmaceutical Safety Assessment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Safety Assessment Market

• 18.1. Taiwan Pharmaceutical Safety Assessment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Safety Assessment Market

• 19.1. South East Asia Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Safety Assessment Market

• 20.1. Western Europe Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Safety Assessment Market

• 21.1. UK Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Safety Assessment Market

• 22.1. Germany Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Safety Assessment Market

• 23.1. France Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Safety Assessment Market

• 24.1. Italy Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Safety Assessment Market

• 25.1. Spain Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Safety Assessment Market

• 26.1. Eastern Europe Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Safety Assessment Market

• 27.1. Russia Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Safety Assessment Market

• 28.1. North America Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Safety Assessment Market

• 29.1. USA Pharmaceutical Safety Assessment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Safety Assessment Market

• 30.1. Canada Pharmaceutical Safety Assessment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Safety Assessment Market

• 31.1. South America Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Safety Assessment Market

• 32.1. Brazil Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Safety Assessment Market

• 33.1. Middle East Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Safety Assessment Market

• 34.1. Africa Pharmaceutical Safety Assessment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Pharmaceutical Safety Assessment Market, Segmentation By Type, Segmentation By Drug Type, Segmentation By Phase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Safety Assessment Market Regulatory and Investment Landscape

36. Pharmaceutical Safety Assessment Market Competitive Landscape And Company Profiles

• 36.1. Pharmaceutical Safety Assessment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Pharmaceutical Safety Assessment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Pharmaceutical Safety Assessment Market Company Profiles
  • 36.3.1. IQVIA Holding Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. LabCorp (formerly Covance) Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Thermo Fisher Scientific (PPD) Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Safety Assessment Market Other Major And Innovative Companies

• Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc.

38. Global Pharmaceutical Safety Assessment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Safety Assessment Market

40. Pharmaceutical Safety Assessment Market High Potential Countries, Segments and Strategies

• 40.1 Pharmaceutical Safety Assessment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Pharmaceutical Safety Assessment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Pharmaceutical Safety Assessment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer